Weisheng Xu

发表

Histone deacetylase inhibitors selectively suppress expression of HDAC7

G. Perez, L. Ngo, P. Marks, 2007, Molecular Cancer Therapeutics.

Diffuse talc granulomatosis in a patient with Crohn's disease.

Weisheng Xu, I. Reder, A. Caperna, 2012, American journal of respiratory and critical care medicine.

Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor

G. Perez, L. Ngo, P. Marks, 2006, Proceedings of the National Academy of Sciences.

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin

H. Scher, P. Marks, L. Butler, 2002, Proceedings of the National Academy of Sciences of the United States of America.

A concise update on prostate pathology.

Ming Zhou, Weisheng Xu, 2014, Ceskoslovenska patologie.

Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma.

J. Melamed, F. Deng, Ming Zhou, 2014, American journal of clinical and experimental urology.

Solid variant of papillary cystadenoma of the epididymis

J. Melamed, F. Deng, Ming Zhou, 2015, Histopathology.

Rapid on-site evaluation with dynamic telecytopathology for ultrasound-guided fine-needle aspiration of head and neck nonthyroid lesions

Dongliang Wang, A. Swarnkar, K. Khurana, 2015, Journal of pathology informatics.

Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects.

G. Perez, L. Ngo, P. Marks, 2005, Cancer research.

Molecular testing in lung cancer: Fine‐needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication

H. Raftopoulos, Weisheng Xu, Chiara Sugrue, 2014, Cancer cytopathology.

Destaining of Diff-Quik stained cytologic smears is not necessary for the detection of anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma by fluorescence in situ hybridization

Shengle Zhang, K. Khurana, Jamie Tull, 2016, Journal of cytology.

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors.

G. Perez, L. Ngo, P. Marks, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Histone deacetylase inhibitors: molecular mechanisms of action

P. Marks, R. Parmigiani, P A Marks, 2007, Oncogene.

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1.

L. Ngo, P. Marks, V. Richon, 2004, Proceedings of the National Academy of Sciences of the United States of America.

HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation

P. Marks, H. Erdjument-Bromage, P. Tempst, 2008, Proceedings of the National Academy of Sciences.

Molecular testing in lung cancer: Fine‐needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication

H. Raftopoulos, Weisheng Xu, Chiara Sugrue, 2014, Cancer cytopathology.